Skip to main content

Table 3 Patient characteristics at baseline categorized by the uNGAL cut off level of 56 ng/mL

From: Urine neutrophil gelatinase-associated lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions

Variables Total uNGAL <56 ng/mL uNGAL ≥56 ng/mL P
% or mean ± SD (n = 121) (n = 71; 58.7 %) (n = 50; 41.3 %)
Age (years) 57.3 ± 14.7 54.7 ± 13.8 61.0 ± 15.3 0.02*
% Male 75 (62 %) 46/71 (65 %) 29/50 (58 %) 0.45
Ascites 68 (56.2 %) 37/71 (52 %) 31/50 (62 %) 0.28
MELD score 14.9 ± 5.7 14.6 ± 6.2 15.4 ± 5.0 0.44
Serum creatinine 0.88 ± 0.29 0.82 ± 0.27 0.97 ± 0.32 0.006*
TB (mg/dl) 4.7 ± 5.1 4.3 ± 4.4 5.2 ± 6.2 0.34
DB (mg/dl) 3.4 ± 4.3 3.1 ± 3.4 3.9 ± 5.4 0.29
AST (U/L) 139.7 ± 250.3 148 ± 283 128 ± 196 0.66
ALT (U/L) 78.4 ± 174.5 74 ± 180 84 ± 168 0.76
ALP (U/L) 163.1 ± 108.1 155 ± 98 174 ± 121 0.35
INR 1.51 ± 0.77 1.4 ± 0.3 1.7 ± 1.1 0.12
Albumin (g/dl) 2.85 ± 0.86 2.8 ± 0.7 2.9 ± 1.0 0.75
Hemoglobin (g/dl) 10.7 ± 2.4 10.7 ± 2.5 10.7 ± 2.2 0.89
WBC count (103/uL) 9.86 ± 6.2 9.9 ± 6.1 9.8 ± 6.3 0.94
Platelet (/103uL) 128 ± 121 113 ± 66 146 ± 169 0.16
Presence of bacterial infection (%) 64/121 (52.8 %) 34/71 (48 %) 30/50 (60 %) 0.19
Length of stay (days) 9.9 ± 9.7 9.1 ± 9.6 11.0 ± 9.9 0.29
No AKI (%) 86/121 (71 %) 63/71 (89 %) 23/50 (46 %) 0.008*
Death (%) 17/121 (14 %) 5/71 (7 %) 12/50 (24 %) <0.0001*
  1. *P < 0.05